The National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology for Colorectal Cancer Screening have been updated. The guidelines now include annual immunohistochemical stool testing with or without a flexible sigmoidoscopy every five years as an alternate screening option for average risk individuals. Additional updates include guidelines for individuals with three rare syndromes (ie, Peutz-Jeghers Syndrome, Juvenile Polposis Syndrome, Hyperplastic Polyposis Syndrome) which put them at greater risk for developing the disease.

For more information visit